Abridge Raises $12.5M in Series A-1 Funding


Abridge, a Pittsburgh, PA-based medical conversation AI company, raised $12.5M in Series A-1 funding.

The round, which bring total funding raised to date to $27m, was led by Wittington Ventures, with participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital. 

The company intends to use the funds to and will contribute to growing its team and expanding its research and development to further improve and automate documentation workflows.

Led by Dr. Shivdev Rao, CEO and co-founder, Abridge provides enterprise-focused documentation solutions that structure and summarize information from any medical conversation, making it easier for systems to reduce provider burnout while also increasing patient satisfaction. Armed with a proprietary dataset derived from more than 1.5 million medical encounters and peer-reviewed papers about medical conversation AI, the company has already helped more than 2,000 clinicians practice at the top of their license and 200,000 patients stay on top of their health.

Abridge has current and upcoming partnerships and pilots in place with other prominent health systems, including each of a top three hospital, payer, and pharmacy as well as a Fortune 5 healthcare company. In addition, it is now making its core machine learning technology available via API, helping care delivery entities integrate with their existing telemedicine and call center platforms. To that end, Abridge also has technology partnerships in place with Twilio, Genesys, Vonage and more to support easy integrations and implementations.